Physician profile
Daniel Warwick Hunsinger
NPI 1245318203
$1,524.76
in general payments reported to CMS, 2019-2025
10 companies · $418 in 2025
The $418 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2021: $18.29 · 2022: $125 · 2023: $281 · 2024: $434 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $643.46 | 2019-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Supernus Pharmaceuticals, INC. | $282.68 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $161.50 | 2025 | Enflonsia, Vaxneuvance, Vaxelis |
| Pfizer INC. | $121.36 | 2019 | |
| Corium, LLC | $115.36 | 2023 | Azstarys |
| Sanofi Pasteur INC. | $92.00 | 2024 | |
| Ironshore Pharmaceuticals INC. | $44.21 | 2019-2023 | Jornay Pm |
| Bavarian Nordic A/S | $23.04 | 2025 | Vivotif |
| Hologic Sales and Service, LLC | $22.99 | 2025 | Aptima |
| Cranial Technologies, INC | $18.16 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hunsinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.